首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
forced vital capacity相关文献:
Forced vital capacity and cross-domain late-onset Pompe disease outcomes: an individual patient-level data meta-analysis.
Berger KI, Kanters S, Jansen JP, Stewart A, Sparks S, Haack KA, Bolzani A, Siliman G, Hamed A.
J Neurol. 2019 Sep;266(9):2312-2321. doi: 10.1007/s00415-019-09401-1. Epub 2019 Jun 11.
PMID:31187190
Pulmonary Sarcoidosis: Beyond Restriction and Forced Vital Capacity.
Obi ON.
Ann Am Thorac Soc. 2023 Jan;20(1):24-26. doi: 10.1513/AnnalsATS.202208-731ED.
PMID:36584989
Using forced vital capacity (FVC) in the clinic to monitor patients with idiopathic pulmonary fibrosis (IPF): pros and cons.
Nathan SD, Wanger J, Zibrak JD, Wencel ML, Burg C, Stauffer JL.
Expert Rev Respir Med. 2021 Feb;15(2):175-181. doi: 10.1080/17476348.2020.1816831. Epub 2020 Sep 28.
PMID:32985286
The Puzzle of Marijuana Use and Forced Vital Capacity.
Wang RJ, Bhakta NR.
Ann Am Thorac Soc. 2024 May;21(5):683-691. doi: 10.1513/AnnalsATS.202312-1010CME.
PMID:38271695
Comparison of Forced and Slow Vital Capacity Maneuvers in Defining Airway Obstruction.
Huprikar NA, Skabelund AJ, Bedsole VG, Sjulin TJ, Karandikar AV, Aden JK, Morris MJ.
Respir Care. 2019 Jul;64(7):786-792. doi: 10.4187/respcare.06419. Epub 2019 Mar 19.
PMID:30890630
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design.
Santermans E, Ford P, Kreuter M, Verbruggen N, Meyvisch P, Wuyts WA, Brown KK, Lederer DJ, Byrne AJ, Molyneaux PL, Sivananthan A, Moor CC, Maher TM, Wijsenbeek M.
Adv Ther. 2019 Nov;36(11):3059-3070. doi: 10.1007/s12325-019-01093-3. Epub 2019 Sep 29.
PMID:31565781
Reduced forced vital capacity in Aboriginal Australians: Biology or missing evidence?
Hall GL, Pearson G.
Respirology. 2015 Jul;20(5):693-4. doi: 10.1111/resp.12552. Epub 2015 May 18.
PMID:25988308
Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations.
Chan R, Lipworth B.
Lung. 2022 Jun;200(3):301-303. doi: 10.1007/s00408-022-00542-1. Epub 2022 Jun 3.
PMID:35662363
Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis.
Maher TM, Stowasser S, Voss F, Bendstrup E, Kreuter M, Martinez FJ, Sime PJ, Stock C.
Respirology. 2023 Dec;28(12):1147-1153. doi: 10.1111/resp.14579. Epub 2023 Aug 30.
PMID:37646126
Relative effects of forced vital capacity and ALSFRS-R on survival in ALS.
Daghlas SA, Govindarajan R; Pooled Resource Open-Access ALS Clinical Trials Consortium.
Muscle Nerve. 2021 Sep;64(3):346-351. doi: 10.1002/mus.27344. Epub 2021 Jun 10.
PMID:34076262
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3